Tag: Novozymes
Novozymes completes merger with Chr. Hansen, new entity named as Novonesis
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
Novozymes to be soon renamed as Novonesis
Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’
BioVoice eMagazine August 2023 | Issue 8 | Volume 4
The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.
Biotech is the key to unlock a sustainable future
From addressing climate change, transforming food systems, and enabling healthier lives, the biotechnology has many more possibilities, writes Krishna Mohan Puvvada, Regional President, India, Novozymes
BioVoice eMagazine February 2023 Issue 2 Volume 4
Click to Read: February 2023 Edition of BioVoice eMagazine
The Cover Story in the February 2023 issue focuses on the ambitious US$ 300 billion bioeconomy...
BioVoice eMagazine January 2023 Issue 1 Volume 4
Click to Read: January 2023 Edition of BioVoice eMagazine
BioVoice News, India's leading B2B news media for BioTech, HealthTech and AgriTech, is celebrating its 7th anniversary...
Novozymes and Chr. Hansen merge to create a global biosolutions company
The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large
Novozymes collaborates with Saipem to create a more sustainable CO2 capture
The partnership will develop new biotech solutions aimed at carbon capture through enzymes
Novozymes embarks on mission to double its revenue by 2030
Unveiling its 2025-strategy, Novozymes sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030.......................
“2021 holds a lot of promise for Novozymes”
In an exclusive interview with BioVoice, Krishna Mohan Puvvada – Regional President and Head, Consumer Biosolutions – India, Novozymes shared interesting insights on the latest activities, learnings from covid, future outlook and much more.................